Literature DB >> 30120501

Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis.

Jack Crozier1, Nathan Papa2,3, Marlon Perera2,3, Brian Ngo2, Damien Bolton2,3, Shomik Sengupta2,3, Nathan Lawrentschuk2,3,4.   

Abstract

PURPOSE: The detection of lymph node metastases in bladder cancer has a significant impact on treatment decisions. Multiple imaging modalities are available to clinicians including magnetic resonance imaging, computed tomography and positron emission tomography. We aimed to investigate the utility of alternate imaging modalities on pre-cystectomy imaging in bladder cancer for the detection of lymph node metastases.
METHODS: We performed systematic search of Web of Science (including MEDLINE), EMBASE and Cochrane libraries in accordance with the PRISMA statement. Studies comparing lymph node imaging findings with final histopathology were included in our analysis. Sensitivity and specificity data were quantified using patient-based analysis. A true positive was defined as a node-positive patient on imaging and node positive on histopathology. Meta-analysis of studies was performed using a mixed-effects, hierarchical logistic regression model.
RESULTS: Our systematic search identified 35 articles suitable for inclusion. MRI and PET have a higher sensitivity than CT while the specificity of all modalities was similar. The summary MRI sensitivity = 0.60 (95% CI 0.44-0.74) and specificity = 0.91 (95% CI 0.82-0.96). Summary PET/CT sensitivity = 0.56 (95% CI 0.49-0.63) and specificity = 0.92 (95% CI 0.86-0.95). Summary CT sensitivity = 0.40 (95% CI 0.33-0.49) and specificity = 0.92 (95% CI 0.86-0.95).
CONCLUSION: MRI and PET/CT provides superior sensitivity compared to CT for detection of positive lymph nodes in bladder cancer prior to cystectomy. There is variability in the accuracy that current imaging modalities achieve across different studies. A number of other factors impact on detection accuracy and these must be considered.

Entities:  

Keywords:  Bladder cancer; Computed tomography; Magnetic resonance imaging; Positron emission tomography; Transitional cell carcinoma

Mesh:

Year:  2018        PMID: 30120501     DOI: 10.1007/s00345-018-2439-8

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  48 in total

1.  A unification of models for meta-analysis of diagnostic accuracy studies.

Authors:  Roger M Harbord; Jonathan J Deeks; Matthias Egger; Penny Whiting; Jonathan A C Sterne
Journal:  Biostatistics       Date:  2006-05-11       Impact factor: 5.899

2.  Prospective evaluation of MRI, ¹¹C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer.

Authors:  H A Vargas; O Akin; H Schöder; S Olgac; G Dalbagni; H Hricak; B H Bochner
Journal:  Eur J Radiol       Date:  2012-07-31       Impact factor: 3.528

3.  Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.

Authors:  Tobias Maurer; Michael Souvatzoglou; Hubert Kübler; Katharina Opercan; Stefan Schmidt; Ken Herrmann; Jens Stollfuss; Gregor Weirich; Bernhard Haller; Jürgen E Gschwend; Markus Schwaiger; Bernd J Krause; Uwe Treiber
Journal:  Eur Urol       Date:  2011-12-14       Impact factor: 20.096

4.  Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.

Authors:  Pascal Zehnder; Urs E Studer; Eila C Skinner; Ryan P Dorin; Jie Cai; Beat Roth; Gus Miranda; Frédéric Birkhäuser; John Stein; Fiona C Burkhard; Sia Daneshmand; George N Thalmann; Inderbir S Gill; Donald G Skinner
Journal:  J Urol       Date:  2011-08-17       Impact factor: 7.450

5.  Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?

Authors:  Zhongyi Yang; Jingyi Cheng; Lingling Pan; Silong Hu; Junyan Xu; Yongping Zhang; Mingwei Wang; Jianping Zhang; Dingwei Ye; Yingjian Zhang
Journal:  Ann Nucl Med       Date:  2012-07-05       Impact factor: 2.668

6.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

7.  Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.

Authors:  F Lista; G Andrés; F Cáceres; F Ramón de Fata; J M Rodríguez-Barbero; J C Angulo
Journal:  Actas Urol Esp       Date:  2013-06-15       Impact factor: 0.994

8.  Staging of bladder carcinoma: MRI-CT-surgical correlation.

Authors:  M A Amendola; G M Glazer; H B Grossman; A M Aisen; I R Francis
Journal:  AJR Am J Roentgenol       Date:  1986-06       Impact factor: 3.959

Review 9.  The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis.

Authors:  Ayman Soubra; Daniel Hayward; Philipp Dahm; Robert Goldfarb; Jerry Froehlich; Gautam Jha; Badrinath R Konety
Journal:  World J Urol       Date:  2016-02-04       Impact factor: 4.226

10.  Magnetic resonance imaging in the staging of bladder cancer.

Authors:  R Persad; J Kabala; D Gillatt; B Penry; J C Gingell; P J Smith
Journal:  Br J Urol       Date:  1993-05
View more
  16 in total

1.  Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.

Authors:  Giovanni Barchetti; Giuseppe Simone; Isabella Ceravolo; Vincenzo Salvo; Riccardo Campa; Francesco Del Giudice; Ettore De Berardinis; Dorelsa Buccilli; Carlo Catalano; Michele Gallucci; James W F Catto; Valeria Panebianco
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

Review 2.  [The role of the vesical imaging-reporting and data system (VI-RADS) for bladder cancer diagnostics-status quo].

Authors:  V Hechler; M Rink; D Beyersdorff; M Beer; A J Beer; V Panebianco; M Pecoraro; C Bolenz; G Salomon
Journal:  Urologe A       Date:  2019-12       Impact factor: 0.639

3.  Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? A systematic review.

Authors:  Jonas Busch; Stefanie Schmidt; Peter Albers; Julia Heinzelbecker; Sabine Kliesch; Julia Lackner; David Pfister; Christian Ruf; Christian Winter; Friedemann Zengerling; Dirk Beyersdorff
Journal:  World J Urol       Date:  2022-01-17       Impact factor: 4.226

Review 4.  [Imaging of oligometastatic disease in selected urologic cancers].

Authors:  S A Koerber; C A Fink; K Dendl; D Schmitt; G Niegisch; E Mamlins; F L Giesel
Journal:  Urologe A       Date:  2021-11-30       Impact factor: 0.639

5.  Glycosylated phospholipid-coated upconversion nanoparticles for bioimaging of non-muscle invasive bladder cancers.

Authors:  Bowen Sun; Sneha Sree Mullapudi; Yong Zhang; Koon Gee Neoh
Journal:  Mikrochim Acta       Date:  2022-08-25       Impact factor: 6.408

6.  Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis.

Authors:  Yuebo Feng; Kai Zhong; Rui Chen; Weibin Zhou
Journal:  Abdom Radiol (NY)       Date:  2022-02-18

Review 7.  Management of Clinically Regional Node-Positive Urothelial Carcinoma of the Bladder.

Authors:  Chanan Reitblat; Joaquim Bellmunt; Boris Gershman
Journal:  Curr Oncol Rep       Date:  2021-02-09       Impact factor: 5.075

Review 8.  The Role of Molecular Imaging in a Muscle-Invasive Bladder Cancer Patient: A Narrative Review in the Era of Multimodality Treatment.

Authors:  Vincenzo Cuccurullo; Giuseppe Danilo Di Stasio; Francesco Manti; Pierpaolo Arcuri; Rocco Damiano; Giuseppe Lucio Cascini
Journal:  Diagnostics (Basel)       Date:  2021-05-11

9.  Long-term results of a single-center prospective randomized trial assessing efficacy of a shortened course of adjuvant chemotherapy after radical cystectomy in patients with locally advanced bladder cancer.

Authors:  Alexander G Zhegalik; Sergey L Polyakov; Alexander I Rolevich; Alexander N Volkov; Alexander A Minich; Vladimir Ju Vasilevich; Andrey A Mokhort; Sergey A Krasny; Oleg G Sukonko
Journal:  Cent European J Urol       Date:  2020-03-23

10.  Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis.

Authors:  Mehdi Kardoust Parizi; Dmitry Enikeev; Petr V Glybochko; Veronika Seebacher; Florian Janisch; Harun Fajkovic; Piotr L Chłosta; Shahrokh F Shariat
Journal:  World J Urol       Date:  2019-09-06       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.